PB2353: PROGNOSTIC VALUE OF TIME FROM SYMPTOMS BEGIN TO START TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA

• Sunil Lakhwani Lakhwani,
• Ignacio Artiles Santana,
• Belén Pérez-Pinilla,
• Alvaro Bienert Garcia,
• Minerva Montalvo Saavedra,
• Marta Díaz-Lopez,
• Carolina De Bonis-Braun,
• María José Rodríguez Salazar,
• Patricia Machado-Machado,
• Miguel Teodoro Hernandez Garcia,
• Jose Maria Raya

Affiliations

Sunil Lakhwani Lakhwani

1 Hospital Universitario de Canarias, Hematology, La Laguna, Spain

Ignacio Artiles Santana

2 University of La Laguna - Medicine Section, La Laguna, Spain

Belén Pérez-Pinilla

1 Hospital Universitario de Canarias, Hematology, La Laguna, Spain

Alvaro Bienert Garcia

1 Hospital Universitario de Canarias, Hematology, La Laguna, Spain

Minerva Montalvo Saavedra

2 University of La Laguna - Medicine Section, La Laguna, Spain

Marta Díaz-Lopez

1 Hospital Universitario de Canarias, Hematology, La Laguna, Spain

Carolina De Bonis-Braun

1 Hospital Universitario de Canarias, Hematology, La Laguna, Spain

María José Rodríguez Salazar

1 Hospital Universitario de Canarias, Hematology, La Laguna, Spain

Patricia Machado-Machado

2 University of La Laguna - Medicine Section, La Laguna, Spain

Miguel Teodoro Hernandez Garcia

1 Hospital Universitario de Canarias, Hematology, La Laguna, Spain

Jose Maria Raya

1 Hospital Universitario de Canarias, Hematology, La Laguna, Spain